Abernethy, D. R., Greenblatt, D. J., Morse, D. S. & Shader, R. I. (1985). Interaction of propoxyphene with diazepam, alprazolam and lorazepam. British Journal of Clinical Pharmacology 19, 51–57.
Adam, K., Adamson, L., Brezinova, V., Hunter, W. M. & Oswald, I. (1976). Nitrazepam: lastingly effective but trouble on withdrawal. British Medical Journal i, 1558–1560.
Allen, J. W., Jawad, S., Oxley, J. & Trimble, M. (1985). Development of tolerance to anticonvulsant effect of clobazam. Journal of Neurology and Neurosurgery Quarterly 48, 284–285.
Anhalt, H. S., Young, R. & Roginsky, M. (1980). Double-blind comparison of ketozolam, diazepam, and placebo in once-a-day vs t.i.d. dosing. Journal of Clinical Psychiatry 41, 386–392.
Anonymous. (1985 a). Lorazepam – A benzodiazepine to choose or avoid? Drug and Therapeutics Bulletin 34, 61–64.
Anonymous. (1985 b). Some problems with benzodiazepines. Drug and Therapeutics Bulletin 23, 21–23.
Anonymous. (1986). Oral benzodiazepines as prophylaxis for epilepsy. Drug and Therapeutics Bulletin 24, 45–46.
Anonymous (1987). Treatment of benzodiazepine dependence. Lancet i, 78–79.
Antonelle, M. & Katz, D. (1977). Lorazepam in the long-term treatment of anxiety associated with gastrointestinal disorders: An open comparison with diazepam. Clinical Therapeutics 1, 140–144.
Aranko, K. (1985). Task-dependent development of cross-tolerance to psychomotor effects of lorazepam in man. Acta Pharmacologica et Toxicologica 56, 373–381.
Aranko, K., Mattila, M. J. & Seppala, T. (1983). Development of tolerance and cross-tolerance to the psychomotor actions of lorazepam and diazepam in man. British Journal of Clinical Pharmacology 15, 545–552.
Aranko, K., Mattala, M. J., Seppala, T. & Aranko, S. (1985 a). The contribution of the metabolites to the tolerance developing to diazepam in man: Relationship to bioassayed serum benzodiazepine levels. Medical Biology 62, 277–284.
Aranko, K., Mattila, M. J. & Bordignon, D. (1985 b). Psychomotor effects of alprazolam and diazepam during acute and subacute treatment, and during the follow-up phase. Acta Pharmacologica et Toxicologica 56, 364–372.
Aranko, K., Seppala, T., Pelliner, J. & Mattila, M. J. (1985 c). Interaction of diazepam or lorazepam with alcohol. Psychomotor effects and bioassayed serum levels after single and repeated doses. European Journal of Clinical Pharmacology 28, 559–565.
Ashton, H. (1984). Benzodiazepine withdrawal: An unfinished story. British Medical Journal 288, 1135–1140.
Ayd, F. J. (1979). Benzodiazepines: Dependence and withdrawal. Journal of the American Medical Association 242, 1401–1402.
Baldessarini, R. J. (1986). Chemotherapy in Psychiatry: Principles and Practice Harvard University Press: London.
BNF. (1986). British National Formulary British Medical Association and the Pharmaceutical Society of Great Britain: London.
Ballenger, J. C. (1984). Psychopharmacology of the anxiety disorders. Psychiatric Clinics of North America 7, 757–771.
Barnard, E. A., Stephenson, F. A., Sigel, E., Mamalaki, C. & Bilbe, G. (1984). The purified GABA/benzodiazepine complex: Retention of multiple functions. Neuropharmacology 23, 813–814.
Barsky, A. J. & Klerman, G. L. (1983). Overview: Hyochondriasis, bodily complaints, and somatic styles. The American Journal of Psychiatry 140, 273–283.
Berlin, R. M. & Conell, L. J. (1983). Withdrawal symptoms after long-term treatment with therapeutic doses of flurazepam: A case report. American Journal of Psychiatry 140, 488–490.
Bond, A. & Lader, M. (1974). The use of analogue scales in rating subjective feelings. British Journal of Medical Psychology 47, 211–218.
Bond, A. & Lader, M. (1981). After effects of sleeping drugs. InPsychopharmacology of Sleep (ed. Wheatley, D.), pp. 177–197. Raven Press: New York.
Bond, A. & Lader, M. (1982). A comparison of the psychotropic profiles of tofisopam and diazepam. European Journal of Clinical Pharmacology 22, 137–142.
Bond, A., Lader, M. & Shrotriya, R. (1983). Comparative effects of a repeated dose regime of diazepam and buspirone on subjective ratings, psychological tests and the EEG. European Journal of Clinical Pharmacology 24, 463–467.
Bosmann, H. B., Case, R. & Di Stefano, P. (1977). Diazepam receptor characterization: Specific binding of a benzodiazepine to macromolecules in various areas of rat brain. FEBS Letters 82, 368–372.
Bowden, C. L. & Fisher, J. G. (1980). Safety and efficacy of long-term benzodiazepine therapy. Southern Medical Journal 73, 1581–1584.
Braestrup, C. & Nielsen, M. (1982). Neurotransmitters and CNS disease. Lancet i, 1030–1034.
Braestrup, C. & Nielsen, M. (1985). Benzodiazepine receptors. Clinical Neuropharmacology 8, s2–s7.
Braestrup, C. & Squires, R. F. (1977). Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)-diazepam binding. Proceedings of the National Academy of Sciences of the USA 74, 3805–3809.
Braestrup, C. & Squires, R. F. (1978). Pharmacological characterization of benzodiazepine receptors in the brain. European Journal of Pharmacology 48, 263–270.
Braestrup, C., Albrechtsen, R. & Squires, R. F. (1977). High densities of benzodiazepine receptors in human cortical areas. Nature 269, 702–704.
Braestrup, C., Nielsen, M. & Squires, R. F. (1979). No changes in rat benzodiazepine receptors after withdrawal from continuous treatment with lorazepam and diazepam. Life Sciences 24, 347–350.
Breimer, D. D., Jochemsen, R. & von Albert, H. H. (1980). Pharmacokinetics of benzodiazepines: Short-acting versus long-acting. Arzneimittelforschung 30, 875–881.
Brosan, L., Broadbent, D., Nutt, D. & Broadbent, M. (1986). Performance effects of diazepam during and after prolonged administration. Psychological Medicine 16, 561–571.
Busto, U. & Sellers, E. M. (1986). Pharmacokinetic determinants of drug abuse and dependence: a conceptual perspective. Clinical Pharmacokinetics 11, 144–153.
Busto, U., Sellers, E. M., Naranjo, C. A., Cappell, H., Sanchez-Craig, M. Sykora, K. (1986). Withdrawal reaction after long term therapeutic use of benzodiazepines. New England Journal of Medicine 315, 854–859.
Carskadon, M. A., Seidel, W. F., Greenblatt, D. J. & Dement, W. C. (1982). Daytime carryover of triazolam and flurazepam in elderly insomniacs. Sleep 5, 361–371.
Chiu, T. H. & Rosenberg, H. C. (1978). Reduced diazepam binding following chronic benzodiazepine treatment. Life Sciences 23, 1153–1158.
Cohn, J. B. & Wilcox, C. S. (1984). Long-term comparison of alprazolam, lorazepam and placebo in patients with an anxiety disorder. Pharmacology 4, 93–98.
Cook, P., Flanagan, R. & James, M. (1984). Diazepam tolerance: Effect of age, regular sedation, and alcohol. British Medical Journal 289, 351–353.
Corfield-Sumner, P. K. & Stolerman, I. P. (1978). Behavioural tolerance. In Contemporary Research in Behavioural Pharmacology (ed. Blackman, D. E. and Sanger, D. J.), pp. 391–448. Plenum Press: New York.
Costa, E. (1985). Benzodiazepine/GABA interactions: A model to investigate the neurobiology of anxiety. In Anxiety and the Anxiety Disorders (ed. Tuma, A. H. and Maser, J.), pp. 27–52. Lawrence Erlbaum: Hillsdale, New Jersey.
Costa, E., Guidotti, A. & Mao, C. C. (1975). Evidence for the involvement of GABA in the action of benzodiazepines: Studies on rat cerebellum. In Mechanisms of Action of Benzodiazepines (ed. Costa, E. and Greengard, P.), pp. 121–156. Raven Press: New York.
Costa, E., Guidotti, A. & Toffano, G. (1978). Molecular mechanisms mediating the action of diazepam on GABA receptors. British Journal of Psychiatry 133, 239–248.
Costa, E., Corda, M. G. & Guidotti, A. (1983). On a brain polypeptide functioning as a putative effector for the recognition sites of benzodiazepine and beta-carboline derivatives. Neuropharmacology 22, 1481–1492.
Covi, L., Lipman, R. S., Pattison, J. H., Derogatis, L. R. & Uhlenhuth, E. H. (1973). Length of treatment with anxiolytic sedatives and response to their sudden withdrawal. Acta Psychiatrica Scandinavica 49, 51–64.
Crawley, J. N., Marangos, P. J., Stivers, J. & Goodwin, F. K. (1982). Chronic clonazepam administration induces benzodiazepine receptor subsensitivity. Neuropharmacology 21, 85–89.
Crown, S. & Crisp, A. H. (1979). Manual of the Crown–Crisp Experiential Index. Hodder and Stoughton: London.
Curry, S. H. & Whelpton, R. (1979). Pharmacokinetics of closely related benzodiazepines. British Journal of Clinical Pharmacology 8, 15S–21S.
Dafters, R. & Anderson, G. (1982). Conditional tolerance to the tachycardia effect of ethanol in humans. Psychopharmacology 78, 365–367.
Dasberg, H. H., Van Der Kleijn, E., Gvelen, P. J. R. & Van Praag, H. (1974). Plasma concentrations of diazepam and of its metabolite n-desmethyl-diazepam in relation to anxiolytic effect. Clinical Pharmacology and Therapeutics 15, 473–483.
Davidoff, R. S. (1973). Alcohol and presynaptic inhibition in an isolated spinal cord preparation. Archives of Neurology 28, 60–63.
Demellweek, C. & Goudie, A. J. (1983). Behavioural tolerance to amphetamine and other psychostimulants: The case for considering behavioural mechanisms. Psychopharmacology 80, 287–307.
Department of Health and Social Security. (1984). Guidelines of Good Clinical Practice in the Treatment of Drug Misuse, Report of the Medical Working Group on Drug Dependence, Elephant and Castle, London.
Di Stefano, P., Case, K. R., Costello, G. D. & Bosmann, H. B. (1979). Increased specific binding of 3H-diazepam in rat brain following chronic diazepam administration. Cellular Biology International Report 3, 163–167.
Dixon, N. F. (1981). Preconscious Processing. Wiley: Chichester.
Dodson, A. & Young, G. (1982). Fluctuations in plasma lorazepam levels during the first six hours after oral administration, Proceedings of the British Pharmacological Society,1st–2nd April 1982. British Journal of Clinical Pharmacology 14, 141P.
Eberts, F. S. (1974). Comparative metabolism of triazolam, a new sedative-hypnotic, in rat, dog and man. Pharmacologist 16, 196–199.
Eberts, F. S. (1977). Disposition of triazolam. Pharmacologist 19, 165–170.
Eberts, F. S., Philopoulos, Y., Reineke, L. M. & Vliek, R. W. (1981). Triazolam disposition. Clinical Pharmacology and Therapeutics 29, 81–93.
Edwards, G. (1984). Addictions as Challenge to Society, the 1984 Upjohn Lecture, University of London. New Society 25 10 1984.
Edwards, J. G., Cantopher, T. & Olivier, S. (1984). Dependence on psychotropic drugs: an overview. Postgraduate Medical Journal 60, 29–40.
Elass, P., Hendel, J., Hvidberg, E. F., Hansen, T., Gymoese, E. & Rathje, J. (1980). Kinetics and neuropsychologic effects of intravenous diazepam in the presence and absence of its active N-desmethyl metabolite in humans. Psychopharmacology 70, 307–312.
Ellinwood, E. H., Heatherly, D. G., Nikaido, A. M., Bjornsson, T. D. & Kilts, S. (1985). Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam. Psychopharmacology 86, 302–309.
Fabre, L. F., McLendon, D. M. & Stephens, A. G. (1981). Comparison of the therapeutic effect, tolerance, and safety of ketazolam and diazepam administered for six months to out-patients with chronic anxiety. Journal of International Medical Research 9, 191–198.
File, S. E. (1981). Rapid development of tolerance to the sedative effects of lorazepam and triazolam in rats. Psychopharmacology 73, 240–245.
File, S. E. (1982). Recovery from lorazepam tolerance and the effects of a benzodiazepine antagonist (Ro 15–1788) on the development of tolerance. Psychopharmacology 77, 284–288.
File, S. E. (1983). Tolerance to the anti-pentylenetetrazole effects of diazepam in the mouse. Psychopharmacology 79, 284–286.
File, S. E. (1984). Behavioural pharmacology of benzodiazepines. Neuropsychopharmacology and Biological Psychiatry 8, 19–31.
File, S. E. (1985). Tolerance to the behavioural actions of benzodiazepines. Neuroscience and Biobehavioural Reviews 9, 113–121.
File, S. E. & Bond, A. J. (1979). Impaired performance and sedation after a single dose of lorazepam. Psychopharmacology 66, 309–313.
File, S. E. & Lister, R. G. (1985). A comparison of the effects of lorazepam with those of propranolol on experimentally-induced anxiety and performance. British Journal of Clinical Pharmacology 19, 445–451.
File, S. E. & Pellow, S. (1985). No cross-tolerance between the stimulatory and depressant actions of benzodiazepines in mice. Behavioural Brain Research 17, 1–7.
Fonagy, P. & Higgitt, A. (1985). Personality Theory and Clinical Practice. Methuen: London.
Fontaine, R., Chouinard, G. & Annable, L. (1984). Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment. American Journal of Psychiatry 141, 848–852.
Frey, H.-H., Philippin, H.-P. & Scheuler, W. (1984). Development of tolerance to the anticonvulsant effect of diazepam in dogs. European Journal of Pharmacology 104, 27–38.
Fuxe, K., Agnati, L. F., Bolme, P., Hokfelt, T., Lidbrink, P., Ljungdahl, A., Mora, M. P. & Ogren, S. O. (1975). The possible involvement of GABA mechanisms in the action of benzodiazepines on central catecholamine neurones. In Mechanisms of Action of Benzodiazepines (ed. Costa, E. and Greengard, P.), pp. 45–61. Raven Press: New York.
Gallager, D. W., Gonsalves, S. F., Rauch, S. L. & Lakoski, J. M. (1984 a). Chronic benzodiazepine treatment decreases post synaptic GABA sensitivity. Nature 308, 74–77.
Gallager, D. W., Rauch, S. L. & Malcolm, A. B. (1984 b). Alterations in a low affinity GABA recognition site following chronic benzodiazepine treatment. European Journal of Pharmacology 98, 159–160.
Geller, I. & Seifter, J. (1960). The effect of meprobamate, barbiturates, d-amphetamine and promazine on experimentally induced conflict in the rat. Psychopharmacologia 1, 482–492.
Ghonheim, M. M., Hinrichs, J. V. & Mewaldt, S. P. (1986). Comparison of two benzodiazepines with differing accumulation: behavioural changes during and after three weeks of dosing. Clinical Pharmacology and Therapeutics 39, 491–500.
Giles, H. G., MacLeod, S. M., Wright, J. R. & Sellers, E. M. (1978). Influence of age and previous use on diazepam dosage required for endoscopy. Canadian Medical Association Journal 118, 513–514.
Goldberg, M. E., Manian, A. A. & Efron, D. H. (1967). A comparative study of certain pharmacologic responses following acute and chronic administration of chlordiazepoxide. Life Sciences 6, 481–499.
Goldberg, D. P., Kay, C. & Thompson, L. (1976). Psychiatric morbidity in general practice and the community. Psychological Medicine 6, 565–569.
Golombok, S. & Lader, M. (1984). The psychopharmacological effects of premazepam, diazepam and placebo in healthy human subjects. British Journal of Clinical Pharmacology 18, 127–133.
Gorenstein, C. & Gentil, V. (1983). Residual and acute effects of flurazepam and triazolam in normal subjects. Psychopharmacology 80, 376–379.
Goudie, A. J. & Demellweek, C. (1986). Conditioning factors in drug tolerance. In Behavioural Analysis of Drug Dependence (ed. Goldberg, S. R. and Stolerman, I. P.), pp. 225–276. Academic Press: London.
Grandison, L. (1983). Actions of benzodiazepines on the neuroendocrine system. Neuropharmacology 22, 1505–1510.
Greeley, J. & Cappell, H. (1985). Associative control of tolerance to the sedative and hypothermic effects of chlordiazepoxide. Psychopharmacology 86, 487–493.
Greenblatt, D. J. (1981). Clinical pharmacokinetics of oxazepam and lorazepam. Clinical Pharmacokinetics 6, 89–105.
Greenblatt, D. J. & Shader, R. I. (1978). Dependence, tolerance and addiction to benzodiazepines: Clinical and pharmacokinetic considerations. Drug Metabolism 8, 13–28.
Greenblatt, D. J. & Shader, R. I. (1986). Long-term administration of benzodiazepines: pharmacokinetic versus pharmacodynamic tolerance. Psychopharmacology Bulletin 22, 416–423.
Greenblatt, D. J., Shader, R. I., Harmatz, J. S. & Georgotas, A. (1979). Self-rated sedation and plasma concentrations of desmethyldiazepam following single doses of clorazepate. Psychopharmacology 66, 289–290.
Greenblatt, D. J., Allen, M. D., Harmatz, J. S. & Shader, R. I. (1980 a). Diazepam disposition determinants. Clinical Pharmacology and Therapeutics 27, 301–311.
Greenblatt, D. J., Ochs, H. R. & Lloyd, B. C. (1980 b). Entry of diazepam and its major metabolite into the cerebrospinal fluid. Psychopharmacology 70, 89–93.
Greenblatt, D. J., Laughren, T. P., Allen, T. P., Hermatz, J. S. & Shader, R. I. (1981). Plasma diazepam and desmethyldiazepam concentrations during long-term diazepam therapy. British Journal of Clinical Pharmacology 11, 35–40.
Greenblatt, D. J., Divoll, M., Abernethy, D. R. & Shader, R. I. (1982). Benzodiazepine hypnotics: kinetic and therapeutic options. Sleep 5, S18–S27.
Greenblatt, D. J., Shader, R. I. & Abernethy, D. R. (1983 a). Drug therapy: Current status of benzodiazepines (first of two parts). The New England Journal of Medicine 309, 354–358.
Greenblatt, D. J., Shader, R. I. & Abernethy, D. R. (1983 b). Drug therapy: Current status of benzodiazepines (second of two parts). The New England Journal of Medicine 309, 410–416.
Greizerstein, H. B. (1979). Development of functional tolerance to pentobarbital in goldfish. Journal of Pharmacology and Experimental Therapeutics 208, 123–127.
Griffiths, A., Tedeschi, G., Smith, A. T. & Richens, A. (1983). The effect of repeated doses of temazepam and nitrazepam on human psychomotor performance. Paper given at British Psychological Society 5–7 January, Welsh National School of Medicine, Cardiff.
Grim, V. E. & Herschkowitz, M. (1981). The effect of chronic diazepam treatment on discrimination performance and 3H-flunitrazepam binding in the brain of shocked and non shocked rats. Psychopharmacology 74, 132–136.
Gross, A. J. (1977). Observations on long-term administration of lorazepam in anxiety states. An open comparison with diazepam. Current Therapy Research 22, 597–604.
Haefely, W. (1983). The biological basis of benzodiazepine actions. Journal of Psychoactive Drugs 13, 19–38.
Haefely, W. (1984). Benzodiazepine interactions with GABA receptors. Neuroscience Letters 47, 201–206.
Haefely, W. (1985). Tranquilizers. In Psychopharmacology 2, Part 1: Preclinical Psychopharmacology, (ed. Grahame-Smith, D. G. and Cowen, P. J.) pp. 92–182. Elsevier: Amsterdam.
Haefely, W. (1986). Biological basis of drug induced tolerance, rebound and dependence: contribution of recent research on benzodiazepines. Pharmacopsychiatry 19, 353–361.
Haefely, W., Kulcsar, A. & Moehler, H. (1975). Possible involvement of GABA in the central actions of benzodiazepines. In Mechanism of Action of Benzodiazepines (ed. Costa, E. and Greengard, P.), pp. 131–151. Raven Press: New York.
Hallstrom, C. and Lader, M. (1981). Benzodiazepine withdrawal phenomena. International Pharmacopsychiatria 16, 235–244.
Hamilton, M. (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology 32, 50–55.
Harrison, M., Busto, U., Naranjo, C. A., Kaplan, H. L. & Sellers, E. M. (1984). Diazepam tapering in detoxification for high-dose benzodiazepine abuse. Clinical and Pharmacological Therapy 35, 527–533.
Haskell, D., Cole, J. O., Schniebolk, S. & Lieberman, B. (1986). A survey of diazepam patients. Psychopharmacology Bulletin 22, 434–438.
Henauer, S., Lombrozo, L. & Hollister, L. E. (1984). Functional tolerance to alprazolam-induced neurologic deficits in mice. Life Sciences 35, 2065–2070.
Hendel, J., Elass, P., Sorensen, K. H., Molter, I. W., Hvidberg, E. F. & Hansen, T. (1980). Anxiety and sedation during a stressful situation after a single dose of diazepam versus N-desmethyl diazepam – a controlled trial. Psychopharmacology 70, 303–305.
Higgitt, A. (1986). The development of tolerance to the benzodiazepines, its long-term persistence and the psychological treatment of severe benzodiazepine dependence, Unpublished M.D. Thesis, University of London.
Higgitt, A., Fonagy, P., Richardson, P. H., Lader, M., Rooney, G. & Mullan, N. (1986 a). The development of tolerance to placebos. Unpublished Manuscript.
Higgitt, A., Lader, M. & Fonagy, P. (1986 b). The effects of the benzodiazepine antagonist Ro 15–1788 on psychophysiological performance and subjective measures in normal subjects. Psychopharmacology 89, 395–403.
Higgitt, A., Golombok, S., Fonagy, P. & Lader, M. (1987). Group treatment of benzodiazepine dependence. British Journal of Addiction 82, 517–532.
Hillestad, L., Hanson, T. & Melsom, H. (1974). Diazepam metabolism in normal man: ii serum concentrations and clinical effect after oral administration and cumulation. Clinical Pharmacology and Therapeutics 16, 495–501.
Hinson, R. E. & Siegel, S. (1980). The contribution of Pavlovian conditioning to ethanol tolerance and dependence. In Alcohol Tolerance, Dependence and Addiction (ed. Rigter, H. and Crabbe, J. C.), pp. 86–98. Elsevier/North-Holland Biomedical Press: Amsterdam.
Hinson, R. E. & Siegel, S. (1983). Anticipatory hyperexcitability and tolerance to the narcotizing effect of morphine in the rat. Behavioural Neuroscience 97, 759–767.
Hironaka, T., Fuchino, K. & Fujii, T. (1983). The benzodiazepine receptor and receptor tolerance produced by chronic treatment of diazepam. Japanese Journal of Pharmacology 33, 95–102.
Hoehn-Saric, R. & MacLeod, D. R. (1986). Physiological and performance responses to diazepam: two types of effects. Psychopharmacology Bulletin 22, 439–443.
Hollister, L. E. (1981). Pharmacology and pharmacokinetics of the tranquillisers. Psychiatric Annals 2 (supplement), 26–31.
Hollister, L. E. (1983). The pre-benzodiazepine era. Journal of Psychoactive Drugs 15, 9–13.
Hollister, L. E., Conley, F. K., Britt, R. H. & Shuer, L. (1981). Longterm use of diazepam. Journal of the American Medical Association 246, 1568–1570.
Hommer, D. W., Matsui, V., Wolkowitz, O., Chrousos, G., Greenblatt, D. J., Weingartner, H. & Paul, S. M. (1986). Benzodiazepine sensitivity in normal human subjects. Archives of General Psychiatry 43, 542–552.
Jochemsen, R., Van der Graaff, M., Joeinjinga, J. K. & Breimer, D. D. (1982). Influence of sex, menstrual cycle and oral contraception on the disposition of nitrazepam. British Journal of Clinical Pharmacology 13, 319–324.
Jochemsen, R., Vanboxtel, C. J., Hermans, J. & Breimer, D. D. (1983). Kinetics of five benzodiazepine hypnotics in healthy subjects. Clinical Pharmacology and Therapeutics 34, 42–47.
Kalant, H., Leblanc, A. E. & Gibbins, D. J. (1971). Tolerance to and dependence on some non-opiate psychotropic drugs. Pharmacological Reviews 23, 123–191.
Kales, A. & Kales, J. D. (1983). Sleep laboratory studies of hypnotic drugs: Efficacy and withdrawal effects. Journal of Clinical Psychopharmacology 3, 140–149.
Kales, A., Kales, J. D. & Bixler, E. O. (1975). Effectiveness of hypnotic drugs with prolonged use: flurazepam and pentobarbital. Clinical Pharmacology and Therapy 18, 356–363.
Kales, A., Scharf, M. B. & Kales, J. D. (1978). Rebound insomnia: a new clinical syndrome. Science 201, 1039–1040.
Kales, A., Scharf, M. B., Kales, J. D. & Soldatos, C. R. (1979). Rebound insomnia. Journal of the American Medical Association 241, 1692–1695.
Kales, A., Soldatos, C. R., Bixler, E. O. & Kales, J. D. (1983). Early morning insomnia with rapidly eliminating benzodiazepines. Science 220, 95–97.
Kales, J. D., Kales, A. & Bixler, E. O. (1984). Biopsychobehavioral correlates of insomnia. V. Clinical characteristics and behavioral correlates. American Journal of Psychiatry 141, 1371–1376.
Kales, A., Soldatos, C. R. & Vela-Bueno, A. (1985). Clinical comparison of benzodiazepine hypnotics with short and long elimination half-lives. In The Benzodiazepines: Current Standards for Medical Practice, (ed. Smith, D. E. and Wesson, D. R.), pp. 121–147. MTP Press: Lancaster.
Kemper, N., Poser, W. & Poser, S. (1980). Benzodiazepinabhängigkeit Deutsche Medizinische Wochenschrift 105, 1707–1712.
Klepner, C. A., Lippa, A. S., Benson, D. I., Sano, M. C. & Beer, B. (1979). Resolution of two biochemically and pharmacologically distinct benzodiazepine receptors. Pharmacology, Biochemistry and Behaviour 11, 457–462.
Koulu, M., Lammintausta, R. and Dahlstrom, S. (1979). Stimulatory effect of acute baclofen administration on human growth hormone secretion. Journal of Clinical Endocrinology and Metabolism 48, 1038–1040.
Laakmann, G., Treusch, J., Eichmeier, A., Schmauss, M., Treusch, U. & Wahlster, U. (1982). Inhibitory effect of phentolamine on diazepam-induced growth hormone secretion and lack of effect of diazepam on prolactin secretion in man. Psychoneuroendocrinology 7, 135–139.
Lacey, R. & Woodward, S. (1985). That's Life Survey on Tranquillisers. BBC Publications: London.
Lader, M. (1981). Benzodiazepine dependence. In The Misuse of Psychotropic Drugs (ed. Murray, P. R., Ghodse, H., Harris, C., Williams, D. and Williams, P.), pp. 13–16. Gaskell: London.
Lader, M. H. (1984). Neurotransmitters and anxiety: Overview. Psychopathology 17, 3–7.
Lader, M. H. & File, S. E. (1987). The biological basis of benzodiazepine dependence. Psychological Medicine 17, 539–547.
Lader, M. H. & Petursson, H. (1983 a). Rational use of anxiolytic/sedative drugs. Drugs 25, 514–528.
Lader, M. H. & Petursson, H. (1983 b). Abuse liability of anxiolytics. In Anxiolytics: Neurochemical, Behavioural and Clinical Perspectives (ed. Malick, J. B., Enna, S. J. and Yamamura, H. I.), pp. 201–214. Raven Press: New York.
Lader, M. H., Curry, S. & Baker, W. J. (1980). Physiological and psychological effects of clorazepate in man. British Journal of Clinical Pharmacology 9, 83–90.
Ladewig, D. (1984). Dependence liability of the benzodiazepines. Drug and Alcohol Dependence 13, 139–149.
Lang, P. (1977). Physiological assessment of anxiety and fear. In Behavioural Assessment (ed. Cone, J. and Hawkins, R.), pp. 179–195. Brunner/Mazel: New York.
Lapierre, Y. D. (1980). Benzodiazepine withdrawal. Canadian Journal of Psychiatry 26, 93–95.
Leblanc, A. E. & Cappel, H. (1977). Tolerance as adaptation: Interactions with behaviour and parallels to other adaptive processes. In Alcohol and Opiates (ed. Blum, K.), pp. 65–77. Academic Press: New York.
Linnoila, M., Erwin, C. W., Brendle, A., Skinner, T. & Routledge, P. A. (1980). Pharmacodynamics and pharmacokinetics of diazepam in an abuser. Acta Pharmacologica et Toxicologica 47, 75–77.
Lippa, A. S., Nash, R. & Greenblatt, E. (1979). Pre-clinical neuropharmacological testing procedures for anxiolytic drugs. In Anxiolytics (ed. Fielding, S. and Lal, H.), pp. 40–60. Pergamon Press: New York.
Little, H. J., Nutt, D. J. & Taylor, S. C. (1987). Bidirectional effects of chronic treatment with agonists and inverse agonists at the benzodiazepine receptor. Brain Research Bulletin 19, 371–378.
Lucki, I. & Rickels, K. (1986). The behavioural effects of benzodiazepines following long-term use. Psychopharmacology Bulletin 22, 424–433.
Lukas, S. E. & Griffiths, R. R. (1984). Precipitated diazepam withdrawal in baboons: effects of dose and duration of diazepam exposure. European Journal of Pharmacology 100, 163–171.
McMillan, D. E. & Leander, J. D. (1978). Chronic chlordiazepoxide and pentobarbital interactions on punished and unpunished behavior. Journal of Pharmacology and Experimental Therapeutics 207, 515–520.
McNicholas, L. F., Martin, W. R. & Cherian, S. (1983). Physical dependence on diazepam and lorazepam in the dog. The Journal of Pharmacology and Experimental Therapeutics 226, 783–789.
Maletzky, B. M. & Klotter, J. (1976). Addiction to diazepam. International Journal of Addiction 11, 95–115.
Marangos, P. J. & Crawley, J. N. (1982). Chronic benzodiazepine treatment increases [3H]muscimol binding in mouse brain. Neuropharmacology 21, 81–84.
Marks, J. (1978). The Benzodiazepines. Use, Overuse, Misuse, Abuse. MTP Press: Lancaster.
Marks, J. (1983). The benzodiazepines – for good or evil. Neuropsychobiology 10, 115–126.
Marks, J. (1985). Chronic anxiolytic treatment: benefit and risk. In Chronic Treatments in Neuropsychiatry (ed. Kemali, D. and Racagni, G.), pp. 35–41. Raven Press: New York.
Martin, I. L. (1982). The benzodiazepines: recent trends. Psychological Medicine 12, 689–693.
Martin, I. L., Brown, C. L. & Doble, A. (1983). Multiple benzodiazepine receptors: structures in the brain or structures in the mind; a critical review. Life Sciences 32, 1925–1933.
Martin, W. R., McNicholas, F. L. & Cherian, S. (1982). Diazepam and pentobarbital dependence in the rat. Life Sciences 31, 721–730.
Mele, L., Sagratella, S. and Massotti, M. (1984). Chronic administration of diazepam to rats causes changes in EEG patterns and in coupling between GABA and benzodiazepine binding sites in vitro. Brain Research 323, 93–102.
Mellinger, G. D., Balter, M. B. & Uhlenhuth, E. H. (1984). Prevalence and correlates of the long-term regular use of anxiolytics. Journal of the American Medical Association 251, 375–379.
Mendelson, W. B., Goodwin, D. W. & Hill, S. Y. (1976). The morning after: residual effects of triazolam and flurazepam alone and in combination with alcohol. Current Therapeutics and Research 19, 155–163.
Mennini, T., Gobbi, M. & Garattini, S. (1984). Increased number of brain benzodiazepine receptors after in-vivo administration of estazolam to rats. Journal of Pharmacy and Pharmacology 36, 621–622.
Miller, N. E. (1978). Biofeedback and visceral learning. Annual Review of Psychology 29, 378–404.
Moerschbaecher, J. M., Boren, J. J., Schrot, J. & Fontes, J. C. S. (1979). Effects of cocaine and d-amphetamine on the repeated acquisition of response chains. Journal of the Experimental Analysis of Behaviour 31, 127–140.
Mohler, H. & Okada, T. (1977 a). Properties of 3-H-diazepam binding to benzodiazepine receptors in rat cerebral cortex. Life Sciences 20, 2101–2110.
Mohler, H. & Okada, T. (1977 b). Benzodiazepine receptor: demonstration in the central nervous system. Science 198, 849–859.
Mohler, H., Okada, T. & Enna, S. J. (1978). Benzodiazepine and neurotransmitter receptor binding in rat brain after chronic administration of diazepam and phenobarbital. Brain Research 156, 391–395.
Mohler, H., Battersby, M. K. & Richards, J. C. (1980). Benzodiazepine receptor protein identified and visualised in brain tissue by a photoaffinity label. Proceedings of the National Academy of Sciences of the U.S.A. 77, 1666–1670.
Mokler, D. J. & Rech, R. H. (1985). Mechanisms of the initial treatment phenomenon to diazepam in the rat. Psychopharmacology 87, 242–246.
Morgan, K. & Oswald, I. (1982). Anxiety caused by a short-life hypnotic. British Medical Journal 284, 942.
Morre, M., Bachy, A. & Keane, P. E. (1985). Differential CNS binding of benzodiazepines. Supplément Actualilés Médicales Internationales – Psychiatrie 2, 28–32.
Murray, J. (1981). Long-term psychotropic drug taking and the process of withdrawal. Psychological Medicine 11, 853–858.
Naber, D. (1982). Peptides. In Psychopharmacology Part 2 (ed. Hippius, H. and Winokur, G.), pp. 162–177. Excerpta Medica: Amsterdam.
Nelson, J. C., Jatlow, P. I. & Quinlan, D. M. (1984). Subjective complaints during desipramine treatment. Archives of General Psychiatry 41, 55–59.
O'Callaghan, J. P. & Holtzman, S. G. (1976). Prenatal administration of morphine to the rat. Journal of Pharmacology and Experimental Therapeutics 197, 533–544.
Odell, W. D., Rayford, P. L. & Ross, G. T. (1967). Simple partially automated method for radioimmunoassay of human thyroid stimulating, growth, luteinizing and follicle stimulating hormones. Journal of Laboratory and Clinical Medicine 70, 973–980.
Okamoto, M. & Boisse, N. R. (1975). Effect of chronic pentobarbital treatment on blood–cerebrospinal fluid kinetics. European Journal of Pharmacology 33, 205–209.
Olsen, R. W. (1982). Drug interactions at the GABA receptorionophore complex. Annual Review of Pharmacology and Toxicology 22, 245–277.
Orford, J. (1985). Excessive Appetites: A Psychological View of Addictions. Wiley: Chichester.
Oswald, I., French, C., Adam, K. & Gilham, J. (1982). Benzodiazepine hypnotics remain effective for 24 weeks. British Medical Journal 284, 860–863.
Pakes, G. E., Brogden, R. N., Heel, R. C., Speight, T. M. & Avery, G. S. (1981). Triazolam: A review of its pharmacological properties and therapeutic efficacy in patients with insomnia. Drugs 22, 81–101.
Patat, A. & Foulhoux, P. (1985). Effect on postural sway of various benzodiazepine tranquillizers. British Journal of Clinical Pharmacology 20, 9–16.
Pennebaker, J. & Skelton, J. (1978). Psychological parameters of physical symptoms. Personality and Social Psychology Bulletin 4, 524–530.
Pennebaker, J. W. (1980). Perceptual and environmental determinants of coughing. Basic and Applied Social Psychology 1, 83–91.
Pennebaker, J. W. (1982). The Psychology of Physical Symptoms. Springer-Verlag: New York.
Pennebaker, J. W. & Hoover, C. W. (1986). Inhibition and cognition: Toward an understanding of trauma and disease. In Consciousness and Self-regulation (ed. Davidson, R. J., Schwartz, G. E. and Shapiro, D.), pp. 107–136. Plenum Press: New York.
Petersen, E. N., Jensen, L. H., Drejer, J. & Honore, T. (1986). New perspectives in benzodiazepine receptor pharmacology. Pharmacopsychiatry 19, 4–6.
Petrie, A. (1978). Individuality in Pain and Suffering 2nd edn. University of Chicago Press: Chicago.
Petursson, H. (1982). Clinical and Laboratory Studies of Withdrawal from Long-term Benzodiazepine Treatment. Unpublished Ph.D. thesis. University of London.
Petursson, H. & Lader, M. (1983). Benzodiazepine withdrawal syndrome. In New Psychiatric Syndromes: DSM III and Beyond (ed. Akhtar, S.), pp. 177–190. Jason Aronson: New York.
Petursson, H., Shur, E., Checkley, S., Slade, A. & Lader, M. H. (1981). A neuroendocrine approach to benzodiazepine tolerance and dependence. British Journal of Clinical Pharmacology 11, 525–526.
Petursson, H., Gudjonsson, G. H. & Lader, M. H. (1983). Psychometric performance during withdrawal from long-term benzodiazepine treatment. Psychopharmacology 81, 345–349.
Picton, T. W. (1980). The use of human event-related potentials in psychology. In Techniques in Psychophysiology (ed. Martin, I. and Venables, P. H.), pp. 357–395. Wiley: Chichester.
Pinsker, H. & Sujaga-Petchal, K. (1984). Use of benzodiazepines in primary-care geriatric patients. Journal of the American Geriatrics Society 32, 595–597.
Poulos, C. X., Wilkinson, A. D. & Capped, H. D. (1981). Homeostatic regulation and pavlovian conditioning in tolerance to amphetamine-induced anorexia. Journal of Comparative and Physiological Psychology 95, 735–746.
Power, K. G., Jerrom, D. W. A., Simpson, R. J. & Mitchell, M. (1985). Controlled study of withdrawal symptoms and rebound anxiety after six week course of diazepam for generalised anxiety. British Medical Journal 290, 1246–1248.
Preskorn, H. & Denner, L. J. (1977). Benzodiazepines and withdrawal psychosis. Report of three cases. Journal of the American Medical Association 237, 36–38.
Raczynski, J. M., Thompson, J. K. & Sturgis, E. T. (1982). An evaluation of biofeedback assessment and training paradigms. Clinical Psychology Review 2, 337–348.
Rhodes, P. J., Rhodes, R. S. & McCurdy, H. H. (1984). Elimination kinetics and symptomatology of diazepam withdrawal in abusers. Clinical Toxicology 22, 371–385.
Rickels, K. (1981). Are benzodiazepines overused and abused? British Journal of Clinical Pharmacology 11, 71s–83s.
Rickels, K. (1983). Benzodiazepines in emotional disorders. Journal of Psychoaclive Drugs 15, 49–54.
Rickels, K., Case, G. W., Downing, R. W. & Winokur, A. (1983). Long-term diazepam therapy and clinical outcome. Journal of the American Medical Association 250, 767–771.
Rickels, K., Case, G. W., Winokur, A. & Swenson, C. (1984). Longterm benzodiazepine therapy: Benefits and risks. Psychopharmacology Bulletin 20, 608–615.
Rickels, K., Case, W. G., Schweizer, E. E., Swenson, C. & Fridman, B. S. (1986). Low-dose dependence in chronic benzodiazepine users: a preliminary report on 119 patients. Psychopharmacology Bulletin 22, 407–415.
Roache, J. D. & Griffiths, R. R. (1986). Repeated administration of diazepam and triazolam to subjects with histories of drug abuse. Drug and Alcohol Dependence 17, 15–29.
Roehrs, T. A., Zorick, F. J., Wittig, R. M. & Roth, T. (1986). Dose determinants of rebound insomnia. British Journal of Clinical Pharmacology 22, 143–147.
Rosenberg, H. C. & Chiu, T. H. (1979). Decreased 3H-benzodiazepine binding is a specific response to chronic benzodiazepine treatment. Life Sciences 24, 803–808.
Rosenberg, H. C. & Chiu, T. H. (1981). Tolerance during chronic benzodiazepine treatment associated with decreased receptor binding. European Journal of Pharmacology 70, 453–460.
Rosenberg, H. C. & Chiu, T. H. (1982). An antagonist-induced benzodiazepine abstinence syndrome. European Journal of Pharmacology 81, 153–157.
Roth, T., Zorick, F. & Sickelsteel, J. (1981). Benzodiazepines and sleep and wakefulness. British Journal of Clinical Pharmacology 11, 315–355.
Roth, T., Roehrs, T. A. & Zorick, F. J. (1983). Pharmacology and hypnotic efficacy of triazolam. Pharmacotherapy 3, 137–148.
Rutherford, D. M. (1977). Rapid micro-method for the measurement of diazepam and desmethyldiazepam in blood plasma by gas–liquid chromatography. Journal of Chromatography 137, 439–448.
Ryan, G. P. & Boisse, N. R. (1983). Experimental induction of benzodiazepine tolerance and physical dependence. Journal of Pharmacology and Experimental Therapeutics 218, 701–708.
Ryan, G. R. & Boisse, N. R. (1984). Benzodiazepine tolerance, physical dependence and withdrawal: Electrophysiologic study of spinal reflex function. Journal of Pharmacology and Experimental Therapeutics 231, 464–471.
Saletu, B. (1982). Early clinical pharmacology of tranquillizers. In Psychopharmacology 1 Part 2, (ed. Hippius, H. and Winokur, G.), pp. 97–122. Excerpta Medica: Amsterdam.
Salzman, C., Shader, R. I., Greenblatt, D. J. & Harmatz, J. S. (1983). Long v. short half-life benzodiazepines in the elderly – kinetics and clinical effects of diazepam and oxazepam. Archives of General Psychiatry 40, 293–297.
Sanchez-Craig, M., Kay, G., Busto, U. & Cappell, H. (1986). Letter. Lancet i, 388.
Scharff, M. B. & Jacoby, J. A. (1982). Lorazepam – efficacy, side effects, and rebound phenomena. Clinical Pharmacology and Therapeutics 31, 175–179.
Schopf, J. (1983). Withdrawal phenomena after long-term administration of benzodiazepines: A review of recent investigations. Pharmacopsychiatry 16, 1–8.
Schull, J. (1979). A conditioned opponent theory of Pavlovian conditioning and habituation. (ed. Bower, G. H.), pp. 57–90. In The Psychology of Learning and Motivation, vol. 13. Academic Press: New York.
Schulz, R., Wuster, M., Krenss, H. & Herz, A. (1980). Selective development of tolerance without dependence in multiple opiate receptors of mouse vas deferens. Nature 285, 242–243.
Schuster, C. R. & Johanson, C. E. (1981). Environmental variables affecting tolerance development to anorectic drugs. (ed. Garratini, S. and Samanin, R.), pp. 60–93. In Anorectic Agents: Mechanisms of Action and Tolerance. Raven Press: New York.
Sepinwall, J. and Cook, L. (1978). Behavioural pharmacology of anti-anxiety drugs. In Psychopharmacology, Vol. 13 (ed. Iversen, L. L., Iversen, S. D. and Snyder, S. H., pp. 345–393. Plenum Press: New York.
Sepinwall, J. & Cook, L. (1980). Mechanism of action of the benzodiazepines: behavioural aspect. Federation Proceedings 39, 3024–3031.
Sepinwall, J., Gradsky, F. S. & Cook, L. (1978). Conflict behaviour in the squirrel monkey: effects of chlordiazepoxide, diazepam and N-desmethyl diazepam. Journal of Pharmacology and Experimental Therapeutics 204, 88–102.
Seppala, T., Palva, E., Mattila, M. J., Korttila, K. & Shrotriya, R. C. (1980). Tofisopam, a novel 3, 4,-benzodiazepine: Multiple-dose effects on psychomotor skills and memory. Comparison with diazepam and interactions with ethanol. Psychopharmacology 69, 209–218.
Shader, R. I. & Greenblatt, D. J. (1981). The use of benzodiazepines in clinical practice. British Journal of Clinical Pharmacology 11, 5s–9s.
Sher, P. K., Study, R. E., Mazzetta, J., Barker, J. L. & Nelson, P. G. (1983). Depression of benzodiazepine binding and diazepam potentiation of GABA-mediated inhibition after chronic exposure of spinal cord cultures to diazepam. Brain Research 268, 1711–1776.
Shur, E., Petursson, H., Checkley, S. & Lader, M. (1983). Long-term benzodiazepine administration blunts growth hormone response to diazepam. Archives of General Psychiatry 40, 1105–1108.
Seigel, S. (1975). Evidence from rats that morphine tolerance is a learned response. Journal of Comparative and Physiological Psychology 5, 498–506.
Siegel, S. (1983). Classical conditioning, drug tolerance and drug dependence. In Research Advances in Alcohol and Drug Problems, vol. 7, (ed. Israel, Y., Glaser, F. B., Kalant, H., Popham, P. E., Schmidt, W. and Smart, R. G.), pp. 74–93. Plenum: New York.
Siegel, S. (1985). Drug-anticipatory responses in animals. In Placebo Theory, Research and Mechanisms (ed. White, L., Tursky, B. and Schwartz, G. E.), pp. 288–305. The Guildford Press: New York.
Siegel, S. & MacRae, J. (1984). Environmental specificity of tolerance. Trends in Neuroscience 7, 140–143.
Siegel, S., Hinson, R. E. & Krank, M. D. (1981). Morphine-induced attenuation of morphine tolerance. Science 212, 1533–1534.
Sieghard, W. & Karobath, M. (1980). Molecular heterogeneity of benzodiazepine receptors. Nature 286, 285–287.
Skegg, D. C. G., Doll, R. & Perry, J. (1977). Use of medicines in general practice. British Medical Journal i, 1561–1563.
Skolnick, P., Marangos, P. J. & Paul, S. M. (1983). Endogenous ligands of the benzodiazepine receptor. In Anxiolytics: Neurochemical, Behavioural and Clinical Perspectives (ed. Malick, J. B., Enna, S. J. and Yamamura, H. I.), pp. 41–53. Raven Press: New York.
Spinweber, C. L. & Johnson, L. C. (1982). Effects of triazolam (0·5mg) on sleep, performance, memory, and arousal threshold. Psychopharmacology 76, 5–12.
Squires, R. F. (1983). Benzodiazepine receptor multiplicity. Neuropharmacology 22, 1443–1450.
Squires, R. F. & Braestrup, C. (1977). Benzodiazepine receptors in rat brain. Nature 266, 732–734.
Squires, R. F., Benson, D. I., Braestrup, C., Coupet, J., Klepner, C. A., Myers, V. & Beer, B. (1979). Some properties of brain specific benzodiazepine receptors: New evidence for multiple receptors. Pharmacology, Biochemistry and Behaviour 10, 825–830.
Stephens, D. N. & Schneider, H. H. (1985). Tolerance to the benzodiazepine diazepam in an animal model of anxiolytie activity. Psychopharmacology 87, 322–327.
Syvalahti, E. K. G. & Kanto, J. H. (1975). Serum growth hormone, serum immunoreactive insulin and blood glucose response to oral and intravenous diazepam in man. International Journal of Clinical Pharmacology and Biopharmacology 12, 74–82.
Tabakoff, B., Melchio, C. L. & Hoffman, P. L. (1982). Commentary on ethanol tolerance. Alcoholism: Clinical and Experimental Research 6, 252–259.
Tallman, J. F., Paul, S. M., Skolnick, P. & Gallager, D. W. (1980). Receptors for the age of anxiety: pharmacology of the benzodiazepines. Science 207, 274–281.
Tallman, J. F., Mallorga, P., Thomas, J. W. & Gallager, D. W. (1981). GABA and benzodiazepine receptors. In Benzodiazepine Receptors (ed. Costa, E., Dichiara, G. and Gessa, G. L.), pp. 9–18. Raven Press: New York.
Tansella, M., Tansella, Z., Ferrario, L., Preziati, L., Tognoni, G. & Lader, M. (1978). Plasma concentrations of diazepam, nordiazepam and amylobarbitone after short-term treatment of anxious patients. Pharmakopsychiatrie Neuro-psychopharmakologie 11, 67–75.
Tedeschi, G., Griffiths, A. N., Smith, A. T. & Richens, A. (1985). The effect of repeated doses of temazepam and nitrazepam on human psychomotor performance. British Journal of Clinical Pharmacology 20, 361–367.
Thompson, D. M. (1974). Repeated acquisition of behavioural chains under chronic drug conditions. Journal of Pharmacology and Experimental Therapeutics 188, 700–713.
Thompson, D. M. (1977). Development of tolerance to the disruptive effects of cocaine on repeated acquisition and performance of response sequences. Journal of Pharmacology and Experimental Therapeutics 203, 294–302.
Thompson, T. (1984). Behavioural mechanisms of drug dependence. Advances in Behavioural Pharmacology 4, 1–45.
Ticku, M. K. (1983). Benzodiazepine-GABA receptor-ionophore complex: Current concepts. Neuropharmacology 22, 1459–1470.
Ticku, M. K. (1985). Allosteric modulation of benzodiazepine GABA-receptor-ionophore complex by nonbenzodiazepines. Psychiatry and Biological Therapy 18, 47–48.
Ticku, M. K. & Maksay, G. (1983). Convulsant/depressant site of action at the allosteric benzodiazepine-GABA receptor ionophore complex. Life Sciences 33, 2363–2375.
Tognoni, G., Gomeni, R., Demaio, D., Alberti, G. G., Franciosi, P. & Scieghi, G. (1975). Pharmacokinetics of n-demethyldiazepam in patients suffering from insomnia and treated with nortriptyline. British Journal of Clinical Pharmacology 2, 227–232.
Treit, D. (1985). Evidence that tolerance develops to the anxiolytic effect of diazepam in rats. Pharmacology, Biochemistry and Behaviour 22, 383–387.
Tyrer, P., Owen, R. & Dawling, S. (1983). Gradual withdrawal of diazepam after long-term therapy. Lancet i, 1402–1406.
Tyrer, P., Rutherford, D. & Huggett, T. (1981). Benzodiazepine withdrawal symptoms and propranolol. Lancet i, 520–522.
Tyrer, P., Treasaden, I., Moreton, K., Riley, P., Flanagan, R. J. & Dawling, S. (1984). Value of serum diazepam and nordiazepam measurements in anxious patients. Journal of Affective Disorders 7, 1–10.
Vellucci, S. & File, S. (1979). Chlordiazepoxide loses its anxiolytic action with long-term treatment. Psychopharmacologia 21, 1–7.
Vogel, G. W., Barker, K. & Gibbons, P. (1976). A comparison of the effects of flurazepam 30 mg and triazolam 0·5.mg on the sleep of insomniacs. Psychopharmacology 47, 81–86.
Walsh, J. K., Schweitzer, P. K. & Parwatikar, S. (1983). Effects of lorazepam and its withdrawal on sleep, performance and subjective state. Clinical Pharmacology and Therapeutics 34, 496–500.
Waterhouse, B. D., Moises, H. C., Geller, H. M. & Woodward, D. J. (1984). Comparison of norepinephrine- and benzodiazepineinduced augmentation of purkinje cell responses to GABA. Journal of Pharmacological and Experimental Therapeutics 228, 257–267.
Wesson, D. R. & Smith, D. E. (1982). Low dose benzodiazepine withdrawal syndrome: Receptor site mediated. California Society For the Treatment of Alcoholism and Other Drug Dependencies News 9, 1–5.
Wilkinson, M., Moger, W. H. & Grovestine, D. (1980). Chronic treatment with valium (diazepam) fails to affect the reproductive system of the male rat. Life Sciences 27, 2285–2291.
Williams, E. J. (1949). Experimental designs balanced for the estimation of residual effects of treatments. Australian Journal of Scientific Research 2, 149–156.
Winer, B. (1971). Statistical Principles in Experimental Design, 2nd edn. McGraw-Hill: New York.
Winokur, A., Rickels, K., Greenblatt, D. J., Snyder, P. J. & Schats, N. J. (1980). Withdrawal reaction from long-term administration of diazepam. Archives of General Psychiatry 37, 101–105.
Young, W. S. III, Niehoff, D., Kuhar, M. J., Beer, B. & Lippa, A. S. (1981). Multiple benzodiazepine receptor localization by light microscopic radiohistochemistry. Journal of Pharmacological and Experimental Therapeutics 216, 425–430.
Zipursky, R. B., Baker, R. W. & Zimmer, B. (1985). Alprazolam withdrawal delirium unresponsive to diazepam: Case report. Journal of Clinical Psychiatry 46, 344–345.